Suche
Mein Konto
Revolutionary study: Stem cell rejuvenation could bring healing!
Researchers at Children's Hospital of Philadelphia are studying a new mRNA therapy to rejuvenate bone marrow stem cells with Turn Biotechnologies.
Revolutionary study: Stem cell rejuvenation could bring healing!
Researchers at Children’s Hospital of Philadelphia (CHOP) are on the verge of a medical breakthrough! Turn Biotechnologies has unveiled a revolutionary study evaluating ERA™ therapy, which aims to rejuvenate bone marrow stem cells. This epigenetic reprogramming could be crucial to offer patients a better chance of recovery after a stem cell transplant and to significantly increase the quality of the transplanted cells. With support from the Methuselah Foundation, researchers are investigating how stem cell rejuvenation can improve the production of crucial immune cells. According to Timothy Olson, the lead investigator, older stem cells, if rejuvenated, could reduce the risk of diseases such as leukemia.
New ways to cell rejuvenation
The blood progenitor cells examined in the year-long study come from mice and will be transplanted to test the effectiveness of the ERA solution. David Gobel, CEO of the Methuselah Foundation, is optimistic that this research could not only revolutionize medical practice, but also has the potential to extend human lifespan. But that's not all: Turn Biotechnologies recently received positive feedback during an FDA INTERACT session about their therapy TRN-001, which is designed to repair damaged skin cells at the cellular level. The company uses its innovative ERA™ technology to ensure that the treatment is targeted and effective.
The combination of these two study positions shows the enormous growth potential for Turn Biotechnologies in cell rejuvenation therapy. Anja Krammer, CEO of Turn Bio, said she was pleased with the positive feedback from the FDA and sees the company in an excellent position to be the first to introduce cell rejuvenation therapy into clinical applications. This could be crucial to combat chronic, age-related diseases and improve the quality of life for millions of people, while expanding the possibilities for future medical advances, such as by OTS and PR Newswire reported.